BNP Paribas Financial Markets’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-2,571
| Closed | -$47.3K | – | 4232 |
|
|
2020
Q4 | $47.3K | Sell |
2,571
-478
| -16% | -$8.71K | ﹤0.01% | 3579 |
|
|
2020
Q3 | $55.9K | Buy |
3,049
+2,583
| +554% | +$43.4K | ﹤0.01% | 3422 |
|
|
2020
Q2 | $6.98K | Sell |
466
-3,292
| -88% | -$47K | ﹤0.01% | 3867 |
|
|
2020
Q1 | $59.5K | Buy |
3,758
+1,670
| +80% | +$27K | ﹤0.01% | 3460 |
|
|
2019
Q4 | $33.9K | Buy |
2,088
+162
| +8% | +$2.7K | ﹤0.01% | 3845 |
|
|
2019
Q3 | $28.6K | Buy |
1,926
+333
| +21% | +$4.49K | ﹤0.01% | 3777 |
|
|
2019
Q2 | $26.3K | Sell |
1,593
-863
| -35% | -$14.1K | ﹤0.01% | 3797 |
|
|
2019
Q1 | $42.5K | Buy |
2,456
+2,315
| +1,642% | +$42K | ﹤0.01% | 3597 |
|
|
2018
Q4 | $2.49K | Sell |
141
-238
| -63% | -$4.04K | ﹤0.01% | 3759 |
|
|
2018
Q3 | $6.88K | Sell |
379
-8
| -2% | -$164 | ﹤0.01% | 3914 |
|
|
2018
Q2 | $7.57K | Buy |
387
+380
| +5,429% | +$7.12K | ﹤0.01% | 3911 |
|
|
2018
Q1 | $123 | Hold |
7
| – | – | ﹤0.01% | 4147 |
|
|
2017
Q4 | $79 | Hold |
7
| – | – | ﹤0.01% | 4147 |
|
|
2017
Q3 | $75 | Hold |
7
| – | – | ﹤0.01% | 4162 |
|
|
2017
Q2 | $61 | Sell |
7
-58
| -89% | -$511 | ﹤0.01% | 4189 |
|
|
2017
Q1 | $767 | Sell |
65
-167
| -72% | -$2.03K | ﹤0.01% | 3755 |
|
|
2016
Q4 | $3.04K | Sell |
232
-672
| -74% | -$8.99K | ﹤0.01% | 3846 |
|
|
2016
Q3 | $13.1K | Buy |
904
+231
| +34% | +$3.28K | ﹤0.01% | 3096 |
|
|
2016
Q2 | $8.07K | Buy |
673
+593
| +741% | +$9.53K | ﹤0.01% | 3022 |
|
|
2016
Q1 | $1.49K | Sell |
80
-1,676
| -95% | -$27.8K | ﹤0.01% | 2461 |
|
|
2015
Q4 | $37.7K | Sell |
1,756
-735
| -30% | -$15.5K | ﹤0.01% | 2999 |
|
|
2015
Q3 | $42.2K | Buy |
2,491
+1,672
| +204% | +$41.6K | ﹤0.01% | 2989 |
|
|
2015
Q2 | $30.7K | Buy |
+819
| New | +$26.4K | ﹤0.01% | 2780 |
|
BNP Paribas Financial Markets's CBMG Position: Q1 2021 in Review
BNP Paribas Financial Markets sold out of Cellular Biomedicine Group, Inc. (CBMG) in Q1 2021, closing a stake of 2,571 shares — an estimated $47.3K sold.
BNP Paribas Financial Markets first reported a position in CBMG in Q2 2015 and held it in 23 quarters. The position peaked at $59.5K in Q1 2020. 0 funds tracked by Wall St. Rank hold CBMG as of Q1 2021.
- BNP Paribas Financial Markets reported no remaining Cellular Biomedicine Group, Inc. position as of Q1 2021 after selling out during the quarter.
- BNP Paribas Financial Markets sold 2,571 Cellular Biomedicine Group, Inc. shares in Q1 2021, an estimated $47.3K.
- BNP Paribas Financial Markets first reported a position in Cellular Biomedicine Group, Inc. in Q2 2015 and held it in 23 quarters.
- BNP Paribas Financial Markets's Cellular Biomedicine Group, Inc. position peaked at $59.5K in Q1 2020.
- 0 funds tracked by Wall St. Rank held Cellular Biomedicine Group, Inc. as of Q1 2021.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2021, filed 7 May 2021.